Neuroren SRL
Neuroren reported total assets of 684,547 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Oct 2026).
The score of Neuroren shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +111 % Total assets +43 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Neuroren's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 197,321 € | ||||
| Equity | 579,049 € | ||||
| Cash | 353,195 € | ||||
| EBITDA | 306,921 € | ||||
| Total assets | 684,547 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Oct 2026
- Year ended 31 Dec 2024filed on 28 Sep 2025
- Year ended 31 Dec 2023filed on 19 Aug 2024
- Year ended 31 Dec 2022filed on 08 Oct 2023
- Year ended 31 Dec 2021filed on 11 Nov 2022
Neuroren's financial analysis
- Solvency84.6%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Neuroren
Neuroren's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0881.824.921
- VAT number
- BE0881824921
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 13 Jun 2006
- Registered office
- 2550 Kontich
- Latest accounts
- 2025 · filed on 03 Oct 2026
- Activity
- Medical specialists activities (NACE 86220)
Neuroren (SRL) has been based in Kontich since 2006, active in: medical specialists activities. For 2025, it reports a net profit of 197,321 € and equity of 579,049 €; its revenue is not published. Its solvency stands at 84.6%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Neuroren
Companies in the same business, of comparable size and area, outside its group.
- Ocularis Medical specialists activities Antwerp · balance sheet 688,773 €
- Femenina Medical specialists activities Woluwe-Saint-Pierre · balance sheet 684,629 €
- Baudrez RX Medical specialists activities Assesse · balance sheet 688,564 €
- VELX Medical specialists activities Waterloo · balance sheet 684,573 €
- Dr. R. Brummans - Anesthesie Medical specialists activities Oud-Turnhout · balance sheet 684,397 €
- Dr. Jo Buyens - Anesthesie Medical specialists activities Kapelle-op-den-Bos · balance sheet 684,354 €
- Dr. Rasquin-DR. van Langenhove Medical specialists activities Destelbergen · balance sheet 815,769 €
- Dr. Guido Van Hamme, geriatrie Medical specialists activities Leuven · balance sheet 684,991 €
Frequently asked questions about Neuroren
What is the revenue of Neuroren?
Neuroren files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Neuroren?
In Belgium, the VAT number is the company number prefixed with BE: BE0881824921 for Neuroren, if the company is VAT-registered. Its company number (CBE) is 0881.824.921.
Where is the registered office of Neuroren?
According to the CBE register, the registered office of Neuroren is in 2550 Kontich.
What is the equity of Neuroren?
At the close of the 2025 financial year, the equity of Neuroren amounts to 579,049 €, a solvency of 84.6% of total assets.
Who manages Neuroren?
The register lists 1 active mandates at Neuroren. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Neuroren
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →